Laboratories of The Rockefeller Institute for Medical Research.
J Exp Med. 1918 Jun 1;27(6):679-87. doi: 10.1084/jem.27.6.679.
The experiments recorded in this paper serve, in the first place, to confirm the experiments of Dixon and Halliburton on the stimulating effect of intravenous injections of extracts of choroid plexus in the secretion of the cerebrospinal fluid, and extend their observations to monkeys. They bring out also the variable effects of the virus of poliomyelitis, variations affected by the quality of the virus and also by the individual powers of resistance to infection possessed by individual monkeys. These factors of variation must be taken into account in performing and interpreting experiments on infection and particularly those on immunity and specific therapy in relation to poliomyelitis. In general it may be said that experimental infection by way of the blood is not easy to produce in monkeys unless some contributing factor, such as the existence of a coincident aseptic meningitis, operates at the same time. And yet Experiments 1 and 2 show that when the strength of the virus is great the injection of relatively considerable quantities suffices to induce infection and paralysis, but not in all instances. The chief outcome of the experiments has been to determine the fact that when the intravenous inoculation of the virus does not in itself suffice to induce infection and paralysis, the intravenous injection of extracts of the choroid plexus, which in themselves excite the secretory functions which preside over the formation of the cerebrospinal fluid, is powerless to modify this result. This fact would seem to be of interest and importance, since it has already been shown that very slight structural changes in the meningeal-choroidal complex suffice to make possible or certain infection under these circumstances. Apparently mere augmentation, from time to time, of the secretory functions of the choroid plexus, through intravenous injection of an extract of the choroid plexus and while the virus is still circulating, is insufficient to insure passage of the virus from the blood into the nervous tissues, upon which infection depends. Neither does the augmentation exercise a restraining influence on the development of infection otherwise capable of taking place.
本文记录的实验首先证实了 Dixon 和 Halliburton 关于静脉内注射脉络丛提取物刺激脑脊液分泌的实验,并将其观察结果扩展到猴子身上。它们还揭示了脊髓灰质炎病毒的可变效应,这些变异受病毒质量和个体对感染的抵抗力的个体差异的影响。在进行感染实验,特别是与脊髓灰质炎有关的免疫和特效治疗实验时,必须考虑到这些变异因素。一般来说,可以说除非同时存在某种促进因素,如同时存在无菌性脑膜炎,否则通过血液进行实验性感染在猴子中不易产生。然而,实验 1 和 2 表明,当病毒的强度很大时,注射相对大量的病毒就足以引起感染和瘫痪,但并非在所有情况下都是如此。实验的主要结果是确定了这样一个事实,即当静脉内接种病毒本身不足以引起感染和瘫痪时,静脉内注射脉络丛提取物本身会刺激支配脑脊液形成的分泌功能,但也无法改变这一结果。这一事实似乎具有一定的意义和重要性,因为已经表明,脑膜-脉络丛复合体的微小结构变化足以在这些情况下使感染成为可能或确定。显然,仅仅通过静脉内注射脉络丛提取物来不时增加脉络丛的分泌功能,而病毒仍在循环中,不足以保证病毒从血液进入依赖感染的神经组织。这种增加也不会对本来可能发生的感染发展产生抑制作用。